It's still unclear if all patients, particularly those with insurance coverage, will see more cost savings from using that ...
As more consumers order up lab tests and genetic screenings, experts say it could impact insurance, loans, and employment decisions.
Correction, Sept. 9: The list price of Zepbound has been revised from an earlier version of this article. Eli Lilly’s decision to sell its obesity drug Zepbound directly to patients for $499 per month ...
Disney recently introduced its new direct-to-consumer (DTC) streaming service, which will be named ESPN, after its successful sports network, and costs $29.99 per month for the unlimited package and ...
Medicine is expensive and only seems to get more so every year. But this doesn’t have to be inevitable. The reason patients pay so much is an insurance industry that no longer functions like insurance ...
On January 27, 2026, the Department of Health and Human Services, Office of Inspector General (“OIG”) published a Special Advisory Bulletin ...
Three Motley Fool contributors examine formerly highly valued retail brands like Allbirds, Peloton, and Casper. In this podcast, Motley Fool contributors Travis Hoium, Lou Whiteman, and Rachel Warren ...
A major shift is gaining momentum within the pharmaceutical industry, and Jay Bhaumik, Chairman of Thesis Pharmacy, is a notable participant in the movement that makes pharmaceuticals available ...
Go Fast Energy's retail distribution has provided high brand visibility, consumer trust, and valuable purchase data. This retail presence serves as a launchpad for direct-to-consumer growth by: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results